Proposed to up-regulate telomerase activity and modulate gene expression in pinealocytes; binds DNA in vitro.
Reference facts
- Also known as
- Epithalon, AEDG, Epitalamin fragment
- Category
- Khavinson Bioregulators
- Mechanism of action
- Proposed to up-regulate telomerase activity and modulate gene expression in pinealocytes; binds DNA in vitro.
- Targets
- Telomerase (proposed), DNA-binding
- Indications under research or approved
- Russian gerontology research; not US-approved
- Regulatory status (reference entry)
- Not FDA-approved
- Half-life
- Minutes in plasma; epigenetic effects suggested to persist
- Sequence
- AEDG
- Sequence notes
- Tetrapeptide developed by V. Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology.
- Molecular weight (Da)
- 390
- Originator / sponsor
- Khavinson Peptides (Russia)
- First reported
- 1990
Primary References
Explore research articles about Epitalon
This is an educational reference, not medical advice. Research findings do not establish safety or efficacy for self-administration. Consult the primary sources for study populations, limitations, and current regulatory status.